A double-blind augmentation study of levetiracetam in obsessive compulsive disorder.
Phase of Trial: Phase II/III
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Levetiracetam (Primary) ; Sertraline
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 13 Aug 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
- 13 Aug 2008 Planned end date changed from 1 Nov 2007 to 1 Apr 2008 as reported by ClinicalTrials.gov
- 15 Oct 2006 New trial record.